Xanthohumol microbiome and signature in healthy adults (the XMaS trial): a phase I triple-masked, placebo-controlled clinical trial

BACKGROUND: Natural products may provide a source for the discovery and development of adjunctive pharmacological interventions to modulate the inflammatory pathways contributing to chronic disease. Xanthohumol, a flavonoid from the hops plant (Humulus lupulus), has antioxidant and anti-inflammatory...

Descripción completa

Detalles Bibliográficos
Autores principales: Bradley, Ryan, Langley, Blake O., Ryan, Jennifer J., Phipps, John, Hanes, Douglas A., Stack, Emily, Jansson, Janet K., Metz, Thomas O., Stevens, Jan Frederik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542976/
https://www.ncbi.nlm.nih.gov/pubmed/33028396
http://dx.doi.org/10.1186/s13063-020-04769-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542976/
https://www.ncbi.nlm.nih.gov/pubmed/33028396
http://dx.doi.org/10.1186/s13063-020-04769-2

Ejemplares similares